BIOLOGICAL · Unmapped registry intervention
Filgrastim (G-CSF)
Find medicine records ·
Find other trials using this name
Clinical trial
High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
NCT00002837
Drugs and interventions used in this trial
5 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Cyclophosphamide
Normalized identity: cyclophosphamideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Doxorubicin Hydrochloride
Normalized identity: doxorubicin hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
Peripheral Blood Stem Cell Transplantation
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedHigh-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Filgrastim (G-CSF)BIOLOGICAL
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
Doxorubicin HydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002837 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.